Immunalysis Carisoprodol Metabolite / Meprobamate Urine HEIA

Meprobamate Test System

Immunalysis Corporation

The following data is part of a premarket notification filed by Immunalysis Corporation with the FDA for Immunalysis Carisoprodol Metabolite / Meprobamate Urine Heia.

Pre-market Notification Details

Device IDK190397
510k NumberK190397
Device Name:Immunalysis Carisoprodol Metabolite / Meprobamate Urine HEIA
ClassificationMeprobamate Test System
Applicant Immunalysis Corporation 829 Towne Center Drive Pomona,  CA  91767
ContactYang Yang
CorrespondentYang Yang
Immunalysis Corporation 829 Towne Center Drive Pomona,  CA  91767
Product CodeQBK  
CFR Regulation Number862.3590 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2019-02-19
Decision Date2019-11-15

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00840937110294 K190397 000
00840937110287 K190397 000
00840937110270 K190397 000
00840937110263 K190397 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.